Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
Qing Zhou(Guangdong Academy of Medical Sciences), Xiangjiao Meng(Shandong First Medical University), Longhua Sun(Nanchang University), Dingzhi Huang(Tianjin Medical University Cancer Institute and Hospital), Nong Yang(Hunan Cancer Hospital), Y. Yu(Harbin Medical University), Mingfang Zhao(First Hospital of China Medical University), Wu Zhuang(Fujian Provincial Cancer Hospital), Renhua Guo(Jiangsu Province Hospital), Yi Fan Hu(Chinese PLA General Hospital), Yueyin Pan(Anhui Provincial Hospital), Jinlu Shan(Army Medical University), Meili Sun(Jinan Central Hospital), Ying Yuan(Second Affiliated Hospital of Zhejiang University), Yun Fan(Zhejiang Cancer Hospital), Jianan Huang(Soochow University), Lian Liu(Qilu Hospital of Shandong University), Qian Chu(Tongji Hospital), Xiuwen Wang(Qingdao University), Chong‐Rui Xu(Guangdong Academy of Medical Sciences), Jiaxin Lin(Guangdong Academy of Medical Sciences), Jingjing Huang(Soochow University), Mengna Huang(US Biologic (United States)), Jiya Sun(The Fifth People’s Hospital of Suzhou), Sujie Zhang(The Fifth People’s Hospital of Suzhou), Hui Zhou(The Fifth People’s Hospital of Suzhou), Yi‐Long Wu(Guangdong Academy of Medical Sciences)
Cited by 44
Abstract
Related Papers
No related papers found
Powered by citation graph analysis